Metagenomi Therapeutics to Present Preclinical Data on MGX-001 at ASH Annual Meeting

Article summary

Metagenomi Therapeutics announced that its Senior Vice President of Research will present preclinical data for MGX-001, a potential one-time therapy for Hemophilia A, at the 68th American Society of Hematology Annual Meeting.